Macular Degeneration: all 1,490 studies
Page 12 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Non-exudative Age-related Macular DegenerationCompletedNCT01712841
- Neovascular Age-related Macular DegenerationCompletedNCT01712035
- Intervention Trial in Early Age-related Macular DegenerationCompletedNCT01694680Not applicable
- A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular DegenerationCompletedNCT01691261Phase 1
- Diameter Changes of Retinal Vessels During HypoxiaCompletedNCT01689090Not applicable
- Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)CompletedNCT01682382
- Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)CompletedNCT01678963Phase 2
- A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular DegenerationActive, not recruitingNCT01678872Phase 1
- Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt DiseaseTerminatedNCT01676766
- Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)Status unknownNCT01676506Not applicable
- A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMDTerminatedNCT01674829Phase 1/2
- Reading Performance With a Video MagnifierCompletedNCT01670643
- On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT01670162Phase 4
- Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisStatus unknownNCT01669447Phase 4
- A Population-based Study of Macular Choroidal Neovascularization in a Chinese PopulationCompletedNCT01666821
- Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic EyesCompletedNCT01658761Not applicable
- Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term ResultsStatus unknownNCT01657669Phase 4
- VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF AgentsStatus unknownNCT01655589
- Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular DegenerationCompletedNCT01653184Not applicable
- Genetic Load and Phenotype in Aggressive AMDCompletedNCT01650948
- Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)CompletedNCT01648660Not applicable
- Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD PatientsCompletedNCT01644513
- Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)CompletedNCT01638858Not applicable
- Walnuts and Healthy AgingCompletedNCT01634841Not applicable
- Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)CompletedNCT01632527Phase 1/2
- Effect of Intravitreal Anti-VEGF on Retinal Vessels DiameterStatus unknownNCT01626339Not applicable
- Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)CompletedNCT01625559Phase 1
- Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).TerminatedNCT01624636Phase 2
- Long-term Follow-up of Subfoveal Neovascular AMDStatus unknownNCT01608113
- Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular DegenerationTerminatedNCT01601483Phase 2/3
- Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular DegenerationCompletedNCT01600300Phase 1/2
- Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision OutcomesCompletedNCT01581606
- Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival FloraCompletedNCT01577342Not applicable
- Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01570790Phase 1/2
- Lucentis KAV StudyCompletedNCT01570608Phase 3
- Blood and Saliva Sample Collection for AREDS 2CompletedNCT01553474
- Retinal Oximtery Following Treatment for Diabetic MaculopathyCompletedNCT01549132
- Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General DiseasesCompletedNCT01546181
- A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)CompletedNCT01542866Not applicable
- Plaqenil Role in Prevention of Age Related Macular DegenerationStatus unknownNCT01541449
- Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)CompletedNCT01535950Phase 2
- A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the EyeStatus unknownNCT01531842Not applicable
- Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)CompletedNCT01527435
- Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular DegenerationCompletedNCT01526070
- Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular DegenerationStatus unknownNCT01521819Not applicable
- An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationStatus unknownNCT01521065Phase 2
- Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular DegenerationCompletedNCT01518127Not applicable
- IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMDStatus unknownNCT01516294Not applicable
- FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular DegenerationCompletedNCT01500915Phase 4
- EFFECT:Eccentric Fixation From Enhanced Clinical TrainingCompletedNCT01499628Not applicable
- Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationCompletedNCT01494805Phase 1/2
- Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular PigmentCompletedNCT01480700Not applicable
- Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT01469832Phase 1/2
- Genetic Assessment of Early to Late Macular Degeneration StudyCompletedNCT01464710
- Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab DosingCompletedNCT01453920Phase 4
- Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in GermanyCompletedNCT01448538
- Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)CompletedNCT01447043
- A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMDCompletedNCT01436864Phase 3
- Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine SupplementationCompletedNCT01404845Not applicable
- A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular DegenerationCompletedNCT01379560Phase 2
- Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment OutcomesCompletedNCT01363570Not applicable
- Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular DegenerationWithdrawnNCT01361256Early Phase 1
- Study of Dark Adaptation in Age-Related Macular DegenerationCompletedNCT01352975
- Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 NeovascularizationCompletedNCT01350323Not applicable
- Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human EyeStatus unknownNCT01348672
- Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular DystrophyCompletedNCT01345006Phase 1/2
- Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular DegenerationCompletedNCT01344993Phase 1/2
- Vitrectomy for Optic Disc Pit MaculopathyCompletedNCT01340703Not applicable
- Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)WithdrawnNCT01339949Not applicable
- Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)TerminatedNCT01337414Not applicable
- Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)WithdrawnNCT01336907
- Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular DegenerationCompletedNCT01334294
- iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)TerminatedNCT01334255Phase 1
- The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular DegenerationCompletedNCT01330797
- Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01327222Phase 3
- Ranibizumab and the Risk of Arterial Thromboembolic EventsTerminatedNCT01319188Phase 4
- Observe the Effectiveness and Safety of Ranibizumab in Real Life SettingCompletedNCT01318941
- Effects of Xanthophylls on Optical DensityCompletedNCT01316198Not applicable
- Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) TherapyStatus unknownNCT01310686
- Bevacizumab for Neovascular Age-related Macular DegenerationCompletedNCT01306591Not applicable
- Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)CompletedNCT01301443Phase 1
- Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in PortugalCompletedNCT01298674
- Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular AdhesionCompletedNCT01291121Not applicable
- Saffron Supplementation in Stargardt's DiseaseStatus unknownNCT01278277Phase 1/2
- Ozurdex for Macular Edema Post Membrane PeelingCompletedNCT01273727Phase 2/3
- Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus PhotographyCompletedNCT01272063
- Palomid 529 in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01271270Phase 1
- Ranibizumab Short- and Log-term Effects on Retinal Function in wAMDCompletedNCT01269151Not applicable
- Omega-3-fatty Acids on Age-related MacularCompletedNCT01258335Not applicable
- Seven Year Update of Macular Degeneration PatientsCompletedNCT01256827
- Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis TherapyStatus unknownNCT01255774Phase 3
- Intravitreal LFG316 in Patients With Advanced Age-related Macular DegenerationCompletedNCT01255462Phase 1
- Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to RanibizumabStatus unknownNCT01249937Phase 2
- Visual Rehabilitation of Patients With Myopic MaculopathyCompletedNCT01244074Not applicable
- MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMDCompletedNCT01243645Not applicable
- OZURDEX in Age Related Macular Degeneration as Adjunct to RanibizumabCompletedNCT01243086Phase 2
- A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMDCompletedNCT01242254Phase 1/2
- Vascular Endothelial Growth Factor (VEGF) & LOC387715/HTRA1 Polymorphism in Polypoidal Choroidal VasculopathyCompletedNCT01233128
- LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal VasculopathyCompletedNCT01233115
- A Safety Study of CNTO 2476 in Patients With Age-Related Macular DegenerationCompletedNCT01226628Phase 1/2